United States · FDA National Drug Code directory
Linzess
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0456-1203_621456b5-c1a3-48b8-99ac-ccbf8beebf43
- Product NDC
- 0456-1203
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- linaclotide
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170130
- Source listing expiry
- 20271231
Source-listed ingredients
- LINACLOTIDE — 72 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0456-1203-04) / 4 CAPSULE, GELATIN COATED in 1 BOTTLE · 0456-1203-04
- 1 BOTTLE in 1 CARTON (0456-1203-07) / 7 CAPSULE, GELATIN COATED in 1 BOTTLE · 0456-1203-07
- 1 BOTTLE in 1 CARTON (0456-1203-30) / 30 CAPSULE, GELATIN COATED in 1 BOTTLE · 0456-1203-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →